These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7676270)

  • 21. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB.
    Martinez L; Blanc L; Nunn P; Raviglione M
    Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 26. Finding gold in the muddy waters of public health reports.
    Sbarbaro JA
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):689-90. PubMed ID: 15182137
    [No Abstract]   [Full Text] [Related]  

  • 27. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A subset of clinical status of pulmonary tuberculosis in Southern Taiwan.
    Tsai MS; Chong IW; Hwang JJ; Wang TH; Huang MS
    Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):136-9. PubMed ID: 15272756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tuberculosis and immigration: criticality and possible remedial actions].
    D'Auria A; Renzi S; Napoli PA; Franco E
    Ig Sanita Pubbl; 2011; 67(6):793-804. PubMed ID: 22508649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance and supervision of chemotherapy of tuberculosis.
    Sbarbaro JA; Sbarbaro JB
    Semin Respir Infect; 1994 Jun; 9(2):120-7. PubMed ID: 7973171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tuberculosis in African children: epidemiologic, clinical and therapeutic aspects (corrected)].
    Anane R
    Med Trop (Mars); 2003; 63(4-5):473-80. PubMed ID: 14763302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey.
    Espinal MA; Báez J; Soriano G; Garcia V; Laszlo A; Reingold AL; Sanchez S
    Int J Tuberc Lung Dis; 1998 Jun; 2(6):490-8. PubMed ID: 9626607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond directly observed therapy for tuberculosis.
    Nolan CM
    Chest; 1997 May; 111(5):1151-3. PubMed ID: 9149558
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: the treatment of multi-drug resistant tuberculosis--a return to the pre-antibiotic era?
    Ollé-Goig JE
    Trop Med Int Health; 2006 Nov; 11(11):1625-8. PubMed ID: 17054741
    [No Abstract]   [Full Text] [Related]  

  • 40. Tuberculosis -- persistent threat to human health.
    Amdekar YK
    Indian J Pediatr; 2005 Apr; 72(4):333-8. PubMed ID: 15876763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.